Home
Live Updates
Etanercept Biosimilar SDZ ETN Demonstrates Efficacy, Safety in Rheumatic Disease : comparemela.com
Etanercept Biosimilar SDZ ETN Demonstrates Efficacy, Safety in Rheumatic Disease
Patients with rheumatic disease treated with biosimilar SDZ ETN reported high treatment persistence at month 12 as well as comparable safety and efficacy.
Related Keywords
Munich ,
Bayern ,
Germany ,
Docus Herbert Kellner ,
Herbert Kellner ,
Department Of Rheumatology ,
Neuwittelsbach Hospital ,
Disease Activity Score ,
Erythrocyte Sedimentation Rate ,
comparemela.com © 2020. All Rights Reserved.